- Home
- RVMD vs FFIV Comparison
RVMD vs FFIV Comparison
Compare RVMD & FFIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | FFIV |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 14.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | RVMD | FFIV |
|---|---|---|
| Price | $96.61 | $287.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 18 | 10 |
| Target Price | $117.33 | ★ $305.50 |
| AVG Volume (30 Days) | ★ 1.6M | 584.1K |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.56 |
| EPS | N/A | ★ 3.10 |
| Revenue | N/A | ★ $3,088,072,000.00 |
| Revenue This Year | N/A | $8.00 |
| Revenue Next Year | $454.85 | $3.27 |
| P/E Ratio | ★ N/A | $91.65 |
| Revenue Growth | N/A | ★ 9.66 |
| 52 Week Low | $29.17 | $223.76 |
| 52 Week High | $124.49 | $346.00 |
Technical Indicators
Market Signals| Indicator | RVMD | FFIV |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 55.18 |
| Support Level | $93.86 | $255.77 |
| Resistance Level | $107.45 | $303.03 |
| Average True Range (ATR) | 3.03 | 8.56 |
| MACD | -0.30 | -0.09 |
| Stochastic Oscillator | 25.55 | 63.19 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About FFIV F5 Inc.
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.